Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c
Tweet
Share
E-mailGet Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).
For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- S&P announces major changes in S&P 100, S&P 500, S&P 400
- Arcosa stockholders approve $150-per-share cash buyout by CRH
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
